Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11786517 Methods of treatment using a JAK inhibitor compound

Patent 11786517 was granted and assigned to Theravance on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Theravance

Current Assignee

Theravance

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11786517

Patent Inventor Names

Melanie A. Kleinschek

Glenn D. Crater

Date of Patent

October 17, 2023

Patent Application Number

17449136

Date Filed

September 28, 2021

Patent Citations

‌

US Patent 8648069 5-substituted indazoles as kinase inhibitors

‌

US Patent 8895544 Indazoles

‌

US Patent 10100049 JAK kinase inhibitor compounds for treatment of respiratory disease

‌

US Patent 10183942 JAK kinase inhibitor compounds for treatment of respiratory disease

‌

US Patent 10196393 JAK inhibitors containing a 4-membered heterocyclic amide

‌

US Patent 10196418 Phosphorous protecting groups and methods of preparation and use thereof

‌

US Patent 10208040 Fused imidazo-piperidine JAK inhibitors

‌

US Patent 10251874 Crystalline forms of a JAK inhibitor compound

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11786517 Methods of treatment using a JAK inhibitor compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API